International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis

Article Information

Volume / Issue7 / 3 (July-August 2026)
Pages66-70
AccessOpen Access

Publication Timeline

  • Received13 May 2026
  • Accepted11 June 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major parenterally transmitted hepatotropic viruses that frequently present as acute hepatitis, clinically indistinguishable from enterically transmitted hepatitis A and E without laboratory confirmation. Serological markers – hepatitis B surface antigen (HBsAg), IgM antibody to hepatitis B core antigen (IgM anti-HBc), and antibody to hepatitis C virus (anti-HCV) – remain the cornerstone of initial diagnostic evaluation of acute suspected hepatitis. 
Objective: To review the diagnostic serological marker profile and reported prevalence of HBV and HCV among patients with acute suspected hepatitis. Methods: A narrative literature review of peer-reviewed Indian and international studies, surveillance reports, and diagnostic guidelines. 
Results: Hospital-based studies report HBsAg positivity ranging from 2.8% to 16.10% and anti-HCV positivity from 1.8% to 11.98% among acute hepatitis cohorts, considerably higher than community-level estimates. IgM anti-HBc is essential to confirm acute HBV infection, while anti-HCV has reduced sensitivity during the acute window period. 
Conclusion: A structured serological panel combining HBsAg, IgM anti-HBc, and anti-HCV, interpreted within a defined diagnostic algorithm, remains essential for accurate evaluation of acute suspected hepatitis and supports broader viral hepatitis elimination efforts.
 

References

  1. World Health Organization. Global hepatitis report 2024 [Internet]. Geneva: World Health Organization; 2024 [cited 2026 Jun 1 5]. Available from: https://www.who.int/publications/i/item/978924009167 2 [Google Scholar][Crossref]
  2. World Health Organization. Global hepatitis report 2026 [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Jun 1 5]. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/reports/global-hepatitis-report-2026 [Google Scholar][Crossref]
  3. Centers for Disease Control and Prevention. Clinical testing and diagnosis for hepatitis B [Internet]. Atlanta: CDC [cited 2026 Jun 1 5]. Available from: https://www.cdc.gov/hepatitis-b/hcp/diagnosis-testing/index.html [Google Scholar][Crossref]
  4. University of Washington. Core concepts: HBV screening, testing, and diagnosis [Internet]. Seattle: Hepatitis B Online [cited 2026 Jun 15]. Available from: https://www.hepatitisb.uw.edu/go/screening-diagnosis/diagnosis-hbv/core-concept/all [Google Scholar][Crossref]
  5. Irshad M, Singh S, Ansari MA, Joshi YK. Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: a hospital-based study. Indian J Med Microbiol. 2013;31(3):261–5. [Google Scholar][Crossref]
  6. Barde PV, Chouksey VK, Shivlata L, Sahare LK, Thakur AK. Viral hepatitis among acute hepatitis patients attending tertiary care hospital in central India. Virusdisease. 2019;30(3):367–72. [Google Scholar][Crossref]
  7. Mittal G, Gupta P, Gupta R, Ahuja V, Mittal M, Dhar M. Seroprevalence and risk factors of hepatitis B and hepatitis C virus infections in Uttarakhand, India. J Clin Exp Hepatol. 2013;3(4):296–300. [Google Scholar][Crossref]
  8. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63. [Google Scholar][Crossref]
  9. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58–68. [Google Scholar][Crossref]
  10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107. [Google Scholar][Crossref]
  11. Pathology Outlines. Hepatitis B testing [Internet] [cited 2026 Jun 1 5] . Available from: https://www.pathologyoutlines.com/topic/chemistryhep atitisB.html [Google Scholar][Crossref]
  12. Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India. 2006;19(4):203–17. [Google Scholar][Crossref]
  13. Puri P. Tackling the hepatitis B disease burden in India. J Clin Exp Hepatol. 2014;4(4):312–7. [Google Scholar][Crossref]
  14. World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;92(27):369–92. [Google Scholar][Crossref]
  15. Mayo Clinic Laboratories. Hepatitis B virus core total antibodies, with reflex to hepatitis B virus core IgM antibody, serum [Internet] [cited 2026 Jun 1 5] . Available from: https://gi.testcatalog.org/show/CORAB [Google Scholar][Crossref]

How to Cite

Tiwari, S., Rajani, M., & Sengupta, C. (2026). Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis. International Journal of Medical and All Body Health Research, 7(3), 66-70. https://doi.org/10.54660/IJMBHR.2026.7.3.66-70

Tiwari, Shekhar, et al. "Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 66-70. https://doi.org/10.54660/IJMBHR.2026.7.3.66-70.

Tiwari, S., Rajani, M. and Sengupta, C. (2026) 'Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis', International Journal of Medical and All Body Health Research, 7(3), pp. 66-70. doi: 10.54660/IJMBHR.2026.7.3.66-70.

Tiwari S, Rajani M, Sengupta C. Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis. International Journal of Medical and All Body Health Research. 2026;7(3):66-70. doi:10.54660/IJMBHR.2026.7.3.66-70

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.